Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection

By V. Cheng, Susanna K. P. Lau, Patrick C Y Woo, Kwok-Yung Yuen. Clinical Microbiology Reviews, 2007

998 citations recorded by the source corpus.

Subfields: Infectious Diseases, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/dc6ed846a70f5517b6559a43b6dfd89a719521fb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

In Modeling and Simulation

Kwok-Yung Yuen

Citations in the corpus

Zoonotic origins of human coronaviruses (2020, background): “Lymphopenia, deranged liver function tests, and elevated creatine kinase are common laboratory abnormalities of SARS [14, 15] .”
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens (2020, background): “As evidenced by previous epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), highly sensitive and specific laboratory diagnostics for COVID-19 are essential for case identification, contact tracing, animal source finding, and rationalization of infection control”
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis (2018, background): “Due to the ongoing threat and continued emergence of new, highly pathogenic coronaviruses from animal reservoirs, a thorough understanding of the host-virus interactions that drive SARS-CoV pathogenesis will aid the public health response to current and future coronavirus outbreaks (8).”
Hosts and Sources of Endemic Human Coronaviruses (2018, background): “This outbreak affected at least 8000 individuals andwas characterized by a case fatality rate of approximately 10% (Cheng et al., 2007; Drosten et al., 2003).”
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study (2020, background): “[5] [6] [7] [8] [9] Neurological manifestations such as con fusion are infrequently reported in patients with COVID-19 (9·1%) but are almost absent in patients with SARS. 8 Another apparent difference between SARS-CoV-2 and SARS-CoV is the speed at which the COVID-19 outbreak is expanding.”
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease (2015, methodology): “Other forms of assisted ventilation and pulmonary rescue therapy, including mechanical ventilation using a lung-protective strategy with a small tidal volume, noninvasive positive pressure ventilation, and inhaled nitric oxide, have been tried for SARS and influenza with ARDS (3, 153).”
The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis (2020, background): “[54] suggested that the possibility of the re-emergence of novel viruses from animals or laboratories should not be ignored, because bats comprise a vast reservoir of SARS-CoV-like viruses.”
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan (2020, background): “The best-known examples include severe acute respiratory syndrome CoV (SARS-CoV) which emerged in China in 2002-2003 to cause a large-scale epidemic with about 8000 infections and 800 deaths, and Middle East respiratory syndrome CoV (MERS-CoV) which has caused a persistent epidemic in the Arabian Pe”
Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus (2012, background): “Their transcription regulatory sequences (TRSs) conform to the consensus motif 5=-ACACCA-3= (Table 3), which appears to be unique to members of the genus Deltacoronavirus.”
Coronavirus Diversity, Phylogeny and Interspecies Jumping (2009, background): “Among the 7800 ‘‘coronavirus’’ papers found by MEDLINE search, almost half of them were published after the SARS epidemic, which has boosted interest in all directions of coronavirus research, most notably, coronavirus biodiversity and genomics (1).”
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods (2020, neutral): “The therapies that act on the coronavirus can be divided into several categories based on the specific pathways: (1) some acting on enzymes or functional proteins that are critical to virus, preventing the virus RNA synthesis and replication; (2) some acting on structural proteins of virus, blocking”
Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 (2020, background): “over 145 000 deaths within 4 months, whereas the 2002–2003 severe acute respiratory syndrome (SARS) caused by SARS-CoV was controlled within 6 months and only affected 8096 patients with 774 deaths [1, 2].”